| Pamela Quinn, MD | |
|
7633 Al Highway 69, Guntersville, AL 35976-7137 | |
| (256) 753-4345 | |
| (256) 753-3010 |
| Full Name | Pamela Quinn |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 30 Years |
| Location | 7633 Al Highway 69, Guntersville, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457341638 | NPI | - | NPPES |
| 000021152 | Medicaid | AL | |
| 51021152 | Other | AL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 00021758 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Decatur Morgan Hospital - Decatur Campus | Decatur, AL | Hospital |
| Huntsville Hospital | Huntsville, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Decatur Morgan Neurology | 6002116621 | 3 |
News Archive
In findings that could lead to curing some forms of congenital blindness through gene therapy, researchers at UCLA have discovered that RPE65, a gene missing in infants born with the blinding disease Leber congenital amaurosis, is also a key enzyme in the visual cycle. The identity of this enzyme has long been a mystery to scientists.
Seattle Genetics, Inc. (NASDAQ:SGEN), has announced that it has initiated a phase II clinical trial of SGN-35 for patients with relapsed or refractory systemic anaplastic large cell lymphoma (ALCL). SGN-35 is an antibody-drug conjugate (ADC) that utilizes Seattle Genetics' proprietary technology to empower antibodies by linking them to potent cell-killing drugs.
Elena Willis, MD Resident Physician, Department of Otorhinolaryngology - Head and Neck Surgery, Montefiore Medical Center, has been awarded a $10,000 Resident Research Grant by The American Academy of Otolaryngology - Head and Neck Surgery, sponsored by The Oticon Foundation, to develop a tablet computer app to help improve the speech of children with cochlear implants.
Are you contemplating a skiing holiday? The all-out pleasure and enjoyment you experience on a pair of skis or a snowboard is positively priceless to enhance your overall happiness.
› Verified 7 days ago
| Entity Name | North Central Neurology Associates,pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992749626 PECOS PAC ID: 2668413451 Enrollment ID: O20050523000338 |
News Archive
In findings that could lead to curing some forms of congenital blindness through gene therapy, researchers at UCLA have discovered that RPE65, a gene missing in infants born with the blinding disease Leber congenital amaurosis, is also a key enzyme in the visual cycle. The identity of this enzyme has long been a mystery to scientists.
Seattle Genetics, Inc. (NASDAQ:SGEN), has announced that it has initiated a phase II clinical trial of SGN-35 for patients with relapsed or refractory systemic anaplastic large cell lymphoma (ALCL). SGN-35 is an antibody-drug conjugate (ADC) that utilizes Seattle Genetics' proprietary technology to empower antibodies by linking them to potent cell-killing drugs.
Elena Willis, MD Resident Physician, Department of Otorhinolaryngology - Head and Neck Surgery, Montefiore Medical Center, has been awarded a $10,000 Resident Research Grant by The American Academy of Otolaryngology - Head and Neck Surgery, sponsored by The Oticon Foundation, to develop a tablet computer app to help improve the speech of children with cochlear implants.
Are you contemplating a skiing holiday? The all-out pleasure and enjoyment you experience on a pair of skis or a snowboard is positively priceless to enhance your overall happiness.
› Verified 7 days ago
| Entity Name | Decatur Morgan Neurology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144691908 PECOS PAC ID: 6002116621 Enrollment ID: O20151203000195 |
News Archive
In findings that could lead to curing some forms of congenital blindness through gene therapy, researchers at UCLA have discovered that RPE65, a gene missing in infants born with the blinding disease Leber congenital amaurosis, is also a key enzyme in the visual cycle. The identity of this enzyme has long been a mystery to scientists.
Seattle Genetics, Inc. (NASDAQ:SGEN), has announced that it has initiated a phase II clinical trial of SGN-35 for patients with relapsed or refractory systemic anaplastic large cell lymphoma (ALCL). SGN-35 is an antibody-drug conjugate (ADC) that utilizes Seattle Genetics' proprietary technology to empower antibodies by linking them to potent cell-killing drugs.
Elena Willis, MD Resident Physician, Department of Otorhinolaryngology - Head and Neck Surgery, Montefiore Medical Center, has been awarded a $10,000 Resident Research Grant by The American Academy of Otolaryngology - Head and Neck Surgery, sponsored by The Oticon Foundation, to develop a tablet computer app to help improve the speech of children with cochlear implants.
Are you contemplating a skiing holiday? The all-out pleasure and enjoyment you experience on a pair of skis or a snowboard is positively priceless to enhance your overall happiness.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pamela Quinn, MD 7633 Al Highway 69, Guntersville, AL 35976-7137 Ph: (256) 753-4345 | Pamela Quinn, MD 7633 Al Highway 69, Guntersville, AL 35976-7137 Ph: (256) 753-4345 |
News Archive
In findings that could lead to curing some forms of congenital blindness through gene therapy, researchers at UCLA have discovered that RPE65, a gene missing in infants born with the blinding disease Leber congenital amaurosis, is also a key enzyme in the visual cycle. The identity of this enzyme has long been a mystery to scientists.
Seattle Genetics, Inc. (NASDAQ:SGEN), has announced that it has initiated a phase II clinical trial of SGN-35 for patients with relapsed or refractory systemic anaplastic large cell lymphoma (ALCL). SGN-35 is an antibody-drug conjugate (ADC) that utilizes Seattle Genetics' proprietary technology to empower antibodies by linking them to potent cell-killing drugs.
Elena Willis, MD Resident Physician, Department of Otorhinolaryngology - Head and Neck Surgery, Montefiore Medical Center, has been awarded a $10,000 Resident Research Grant by The American Academy of Otolaryngology - Head and Neck Surgery, sponsored by The Oticon Foundation, to develop a tablet computer app to help improve the speech of children with cochlear implants.
Are you contemplating a skiing holiday? The all-out pleasure and enjoyment you experience on a pair of skis or a snowboard is positively priceless to enhance your overall happiness.
› Verified 7 days ago
Rachel Lauren Pope, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 29 Medical Center Lane, Suite A, Guntersville, AL 35976 Phone: 256-705-6437 | |
Dr. Gregory Theodore Ciaccio, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8000 Al Highway 69, Guntersville, AL 35976 Phone: 256-571-8000 | |
Gauri Jain, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2409 Homer Clayton Dr, Guntersville, AL 35976 Phone: 256-582-3203 Fax: 256-582-3216 |